Global Empty Capsules Market Report and Forecast 2023-2031
Global Empty Capsules Market Outlook
The global empty capsules market value was USD 2.27 billion in 2022, driven by the increasing demand for capsule-based pharmaceutical and nutraceutical products across the globe. The market size is anticipated to grow at a CAGR of 7% during the forecast period of 2023-2031 to achieve a value of USD 4.17 billion by 2031.
Empty Capsules Introduction
Empty capsules are an essential component in the pharmaceutical and nutraceutical industries, providing a convenient and effective means of administering medication and dietary supplements. They are typically made from gelatin, derived from animal collagen, or hydroxypropyl methylcellulose (HPMC), a plant-based alternative, and come in various sizes and colors to accommodate different formulations and dosages. The global empty capsules market encompasses both gelatin capsules and non-gelatin capsules, catering to a wide range of applications, including traditional drugs, herbal medicines, and dietary supplements.
Empty Capsules Market Scenario
The global empty capsules market has experienced significant growth in recent years, driven by factors such as the increasing demand for capsule-based pharmaceutical and nutraceutical products, advancements in capsule manufacturing technologies, and a growing preference for vegetarian capsules.
North America: The largest market for empty capsules, driven by factors such as the advanced pharmaceutical and nutraceutical industries, a high prevalence of chronic diseases, and the presence of major capsule manufacturers.
Europe: The second-largest market, with increasing demand for empty capsules due to a growing aging population, a supportive regulatory framework, and an expanding nutraceutical sector.
Asia-Pacific: Expected to witness the highest growth rate due to factors such as a rapidly aging population, increasing prevalence of chronic diseases, and growing investments in healthcare infrastructure.
Empty Capsules Market Segmentations
Market Breakup by Type
- Gelatin Capsules
- Non-Gelatin Capsules
- Immediate-Release Capsules
- Sustained-Release Capsules
- Delayed-Release Capsules
- Antibiotic
- Antibacterial Drugs
- Dietary Supplements
- Antacid
- Antiflatulent Preparations
- Antianemic Preparations
- Anti-Inflammatory Drugs
- Cardiovascular Therapy Drugs
- Cough and Cold Drugs
- Others
- Pharmaceutical Industry
- Nutraceutical Industry
- Cosmetic Industry and Research Laboratories
- North America
- United States of America
- Canada
- Europe
- United Kingdom
- Germany
- France
- Italy
- Others
- Asia Pacific
- China
- Japan
- India
- ASEAN
- Australia
- Others
- Latin America
- Brazil
- Argentina
- Mexico
- Others
- Middle East and Africa
- Saudi Arabia
- United Arab Emirates
- Nigeria
- South Africa
- Others
Key Trends in the Empty Capsules Market
Some key trends of the market are as follows:
- Growing demand for capsule-based pharmaceutical and nutraceutical products: The increasing prevalence of chronic diseases and a growing awareness of the benefits of dietary supplements have contributed to the rising demand for capsule-based products, driving the growth of the empty capsules market.
- Advancements in capsule manufacturing technologies: The development of new technologies, such as capsule filling machines and capsule coating systems, has improved the efficiency and quality of capsule manufacturing, contributing to market expansion.
- Increasing preference for vegetarian capsules: A growing number of consumers are opting for plant-based alternatives to traditional gelatin capsules due to dietary restrictions, religious beliefs, or concerns about animal-derived products, driving the demand for non-gelatin capsules.
Empty Capsules Market: Competitor Landscape
The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
- ACG
- CapsCanada
- Bright Pharma Caps
- Lonza
- SavoiurCaps
- Comed Chemicals Limited.
- NATURAL CAPSULES LIMITED
- Wuhan Carma Technology Co., Ltd.
- Goerlich Pharma GmbH
- NecLife Lifesciences Ltd
- HealthCaps India Ltd.
- Erawat Pharma Limited.
- QUALICAPS
- SUHEUNG co., ltd.
- Fortcaps
- SNAIL PHARMA INDUSTRY
- Roxlor
- Sunil Healthcare Limited
- H & CARE Incorp
- SHAOXING KANGKE CAPSULE CO., LTD
- 1 Preface
- 1.1 Objectives of the Study
- 1.2 Key Assumptions
- 1.3 Report Coverage – Key Segmentation and Scope
- 1.4 Research Methodology
- 2 Executive Summary
- 3 Global Empty Capsules Market Overview
- 3.1 Global Empty Capsules Market Historical Value (2016-2022)
- 3.2 Global Empty Capsules Market Forecast Value (2023-2031)
- 4 Global Empty Capsules Market Landscape
- 4.1 Global Empty Capsules Developers Landscape
- 4.1.1 Analysis by Year of Establishment
- 4.1.2 Analysis by Company Size
- 4.1.3 Analysis by Region
- 4.2 Global Empty Capsules Product Landscape
- 4.2.1 Analysis by Type
- 4.2.2 Analysis by End User
- 4.2.3 Analysis by Applications
- 5 Global Empty Capsules Market Dynamics
- 5.1 Market Drivers and Constraints
- 5.2 SWOT Analysis
- 5.3 Porter’s Five Forces Model
- 5.4 Key Demand Indicators
- 5.5 Key Price Indicators
- 5.6 Industry Events, Initiatives, and Trends
- 5.7 Value Chain Analysis
- 6 Global Empty Capsules Market Segmentation
- 6.1 Global Empty Capsules Market, by Type
- 6.1.1 Market Overview
- 6.1.2 Gelatin Capsules
- 6.1.3 Non-Gelatin Capsules
- 6.2 Global Empty Capsules Market, by Functionality
- 6.2.1 Market Overview
- 6.2.2 Immediate-Release Capsules
- 6.2.3 Sustained-Release Capsules
- 6.2.4 Delayed-Release Capsules
- 6.3 Global Empty Capsules Market, by Application
- 6.3.1 Market Overview
- 6.3.2 Antibiotic
- 6.3.3 Antibacterial Drugs
- 6.3.4 Dietary Supplements
- 6.3.5 Antacid
- 6.3.6 Antiflatulent Preparations
- 6.3.7 Antianemic Preparations
- 6.3.8 Anti-Inflammatory Drugs
- 6.3.9 Cardiovascular Therapy Drugs
- 6.3.10 Cough and Cold Drugs
- 6.3.11 Others
- 6.4 Global Empty Capsules Market, by End User
- 6.4.1 Market Overview
- 6.4.2 Pharmaceutical Industry
- 6.4.3 Nutraceutical Industry
- 6.4.4 Cosmetic Industry and Research Laboratories
- 6.5 Global Empty Capsules Market by Region
- 6.5.1 Market Overview
- 6.5.2 North America
- 6.5.3 Europe
- 6.5.4 Asia Pacific
- 6.5.5 Latin America
- 6.5.6 Middle East and Africa
- 7 North America Empty Capsules Market
- 7.1 Market Share by Country
- 7.2 United States of America
- 7.3 Canada
- 8 Europe Empty Capsules Market
- 8.1 Market Share by Country
- 8.2 United Kingdom
- 8.3 Germany
- 8.4 France
- 8.5 Italy
- 8.6 Others
- 9 Asia Pacific Empty Capsules Market
- 9.1 Market Share by Country
- 9.2 China
- 9.3 Japan
- 9.4 India
- 9.5 ASEAN
- 9.6 Australia
- 9.7 Others
- 10 Latin America Empty Capsules Market
- 10.1 Market Share by Country
- 10.2 Brazil
- 10.3 Argentina
- 10.4 Mexico
- 10.5 Others
- 11 Middle East and Africa Empty Capsules Market
- 11.1 Market Share by Country
- 11.2 Saudi Arabia
- 11.3 United Arab Emirates
- 11.4 Nigeria
- 11.5 South Africa
- 11.6 Others
- 12 Patent Analysis
- 12.1 Analysis by Type of Patent
- 12.2 Analysis by Publication year
- 12.3 Analysis by Issuing Authority
- 12.4 Analysis by Patent Age
- 12.5 Analysis by CPC Analysis
- 12.6 Analysis by Patent Valuation
- 12.7 Analysis by Key Players
- 13 Grants Analysis
- 13.1 Analysis by year
- 13.2 Analysis by Amount Awarded
- 13.3 Analysis by Issuing Authority
- 13.4 Analysis by Grant Application
- 13.5 Analysis by Funding Institute
- 13.6 Analysis by NIH Departments
- 13.7 Analysis by Recipient Organization
- 14 Funding Analysis
- 14.1 Analysis by Funding Instances
- 14.2 Analysis by Type of Funding
- 14.3 Analysis by Funding Amount
- 14.4 Analysis by Leading Players
- 14.5 Analysis by Leading Investors
- 14.6 Analysis by Geography
- 15 Partnership and Collaborations Analysis
- 15.1 Analysis by Partnership Instances
- 15.2 Analysis by Type of Partnership
- 15.3 Analysis by Leading Players
- 15.4 Analysis by Geography
- 16 Regulatory Framework
- 16.1 Regulatory Overview
- 16.1.1 US FDA
- 16.1.2 EU EMA
- 16.1.3 INDIA CDSCO
- 16.1.4 JAPAN PMDA
- 16.1.5 Others
- 17 Supplier Landscape
- 17.1 ACG
- 17.1.1 Financial Analysis
- 17.1.2 Product Portfolio
- 17.1.3 Demographic Reach and Achievements
- 17.1.4 Mergers and Acquisitions
- 17.1.5 Certifications
- 17.2 CapsCanada
- 17.2.1 Financial Analysis
- 17.2.2 Product Portfolio
- 17.2.3 Demographic Reach and Achievements
- 17.2.4 Mergers and Acquisitions
- 17.2.5 Certifications
- 17.3 Bright Pharma Caps
- 17.3.1 Financial Analysis
- 17.3.2 Product Portfolio
- 17.3.3 Demographic Reach and Achievements
- 17.3.4 Mergers and Acquisitions
- 17.3.5 Certifications
- 17.4 Lonza
- 17.4.1 Financial Analysis
- 17.4.2 Product Portfolio
- 17.4.3 Demographic Reach and Achievements
- 17.4.4 Mergers and Acquisitions
- 17.4.5 Certifications
- 17.5 SavoiurCaps
- 17.5.1 Financial Analysis
- 17.5.2 Product Portfolio
- 17.5.3 Demographic Reach and Achievements
- 17.5.4 Mergers and Acquisitions
- 17.5.5 Certifications
- 17.6 Comed Chemicals Limited.
- 17.6.1 Financial Analysis
- 17.6.2 Product Portfolio
- 17.6.3 Demographic Reach and Achievements
- 17.6.4 Mergers and Acquisitions
- 17.6.5 Certifications
- 17.7 NATURAL CAPSULES LIMITED
- 17.7.1 Financial Analysis
- 17.7.2 Product Portfolio
- 17.7.3 Demographic Reach and Achievements
- 17.7.4 Mergers and Acquisitions
- 17.7.5 Certifications
- 17.8 Wuhan Carma Technology Co., Ltd.
- 17.8.1 Financial Analysis
- 17.8.2 Product Portfolio
- 17.8.3 Demographic Reach and Achievements
- 17.8.4 Mergers and Acquisitions
- 17.8.5 Certifications
- 17.9 Goerlich Pharma GmbH
- 17.9.1 Financial Analysis
- 17.9.2 Product Portfolio
- 17.9.3 Demographic Reach and Achievements
- 17.9.4 Mergers and Acquisitions
- 17.9.5 Certifications
- 17.10 NecLife Lifesciences Ltd
- 17.10.1 Financial Analysis
- 17.10.2 Product Portfolio
- 17.10.3 Demographic Reach and Achievements
- 17.10.4 Mergers and Acquisitions
- 17.10.5 Certifications
- 17.11 HealthCaps India Ltd.
- 17.11.1 Financial Analysis
- 17.11.2 Product Portfolio
- 17.11.3 Demographic Reach and Achievements
- 17.11.4 Mergers and Acquisitions
- 17.11.5 Certifications
- 17.12 Erawat Pharma Limited.
- 17.12.1 Financial Analysis
- 17.12.2 Product Portfolio
- 17.12.3 Demographic Reach and Achievements
- 17.12.4 Mergers and Acquisitions
- 17.12.5 Certifications
- 17.13 QUALICAPS
- 17.13.1 Financial Analysis
- 17.13.2 Product Portfolio
- 17.13.3 Demographic Reach and Achievements
- 17.13.4 Mergers and Acquisitions
- 17.13.5 Certifications
- 17.14 SUHEUNG co., ltd.
- 17.14.1 Financial Analysis
- 17.14.2 Product Portfolio
- 17.14.3 Demographic Reach and Achievements
- 17.14.4 Mergers and Acquisitions
- 17.14.5 Certifications
- 17.15 Fortcaps
- 17.15.1 Financial Analysis
- 17.15.2 Product Portfolio
- 17.15.3 Demographic Reach and Achievements
- 17.15.4 Mergers and Acquisitions
- 17.15.5 Certifications
- 17.16 SNAIL PHARMA INDUSTRY
- 17.16.1 Financial Analysis
- 17.16.2 Product Portfolio
- 17.16.3 Demographic Reach and Achievements
- 17.16.4 Mergers and Acquisitions
- 17.16.5 Certifications
- 17.17 Roxlor
- 17.17.1 Financial Analysis
- 17.17.2 Product Portfolio
- 17.17.3 Demographic Reach and Achievements
- 17.17.4 Mergers and Acquisitions
- 17.17.5 Certifications
- 17.18 Sunil Healthcare Limited
- 17.18.1 Financial Analysis
- 17.18.2 Product Portfolio
- 17.18.3 Demographic Reach and Achievements
- 17.18.4 Mergers and Acquisitions
- 17.18.5 Certifications
- 17.19 H & CARE Incorp
- 17.19.1 Financial Analysis
- 17.19.2 Product Portfolio
- 17.19.3 Demographic Reach and Achievements
- 17.19.4 Mergers and Acquisitions
- 17.19.5 Certifications
- 17.20 SHAOXING KANGKE CAPSULE CO., LTD
- 17.20.1 Financial Analysis
- 17.20.2 Product Portfolio
- 17.20.3 Demographic Reach and Achievements
- 17.20.4 Mergers and Acquisitions
- 17.20.5 Certifications
- 18 Global Dental Laboratories Distribution Model (Additional Insight)
- 18.1 Overview
- 18.2 Potential Distributors
- 18.3 Key Parameters for Distribution Partner Assessment
- 19 Key Opinion Leaders (KOL) Insights (Additional Insight)
- 20 Company Competitiveness Analysis (Additional Insight)
- 20.1 Very Small Companies
- 20.2 Small Companies
- 20.3 Mid-Sized Companies
- 20.4 Large Companies
- 20.5 Very Large Companies
- 21 Pricing Models and Strategies (Additional Insight)
- 21.1 Overview
- 21.2 Cost Model
- 21.2.1 Manufacturing Cost Analysis
- 21.2.2 Procurement Cost Analysis
- 21.2.3 Clinical Trial Cost Factors
- 21.3 Pricing Strategies
- 21.3.1 Competitor Pricing Analysis
- 21.3.2 Key Assessment of Product Attributes
- 21.3.3 Pricing Benchmark
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook